Publications

1. Port JD, Rampton KE, Shu Y, Manduca A, Frye MA. Short TE (7) Li-MRS confirms Bi-exponential lithium T2 relaxation in humans and clearly delineates two patient subtypes. J Magn Reson Imaging. 2013 Jun; 37(6):1451-9. Epub 2012 Nov 12. 2283656
   View PubMed
2. Karpyak VM, Winham SJ, Preuss UW, Zill P, Cunningham JM, Walker DL, Lewis KA, Geske JR, Colby CL, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Frye MA, Bazov I, Heit JA, Bakalkin G, Mrazek DA, Biernacka JM. Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Int J Neuropsychopharmacol. 2013 Jun; 16(5):975-85. Epub 2012 Oct 29. 2280234
   View PubMed
3. Frye MA, Ketter TA, Yang R, Calabrese JR. A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder. Value Health. 2013 May; 16(3):A55-6. Epub 2013 May 03. 2325680
   View PubMed
4. Leedahl DD, Cunningham JL, Drake MT, Mundis CB, Kung S, Frye MA, Lapid MI. Hypovitaminosis d in psychiatric inpatients: clinical correlation with depressive symptoms, cognitive impairment, and prescribing practices. Psychosomatics. 2013 May-Jun; 54(3):257-62. Epub 2012 Dec 01. 2287896
   View PubMed
5. Rasmussen KG, Lineberry TW, Galardy CW, Kung S, Lapid MI, Palmer BA, Ritter MJ, Schak KM, Sola CL, Hanson AJ, Frye MA. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013 May; 27(5):444-50. Epub 2013 Feb 20. 2305449
   View PubMed
6. Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA, Leboyer M, Berk M, Malhi GS, Lopez-Jaramillo C, Taylor VH, Dodd S, Frangou S, Hall GB, Fernandes BS, Kauer-Sant'Anna M, Yatham LN, Kapczinski F, Young LT. Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force. Aust N Z J Psychiatry. 2013 Apr; 47(4):321-32. 2329963
   
7. Kung S, Alarcon RD, Williams MD, Poppe KA, Jo Moore M, Frye MA. Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) depression measures in an integrated mood disorders practice. J Affect Disord. 2013 Mar 5; 145(3):341-3. Epub 2012 Sep 25. 2273652
   View PubMed
8. Abulseoud OA, Gitlin M, Altshuler L, Frye MA. Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study. Brain Behav. 2013 Mar; 3(2):89-94. Epub 2013 Jan 18. 2313164
   View PubMed
9. Lapid MI, Drake MT, Geske JR, Mundis CB, Hegard TL, Kung S, Frye MA. Hypovitaminosis D in psychogeriatric inpatients. J Nutr Health Aging. 2013 Mar; 17(3):231-4. 2308233
   View PubMed
10. Post RM, Chang K, Frye MA. Paradigm shift: preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention. J Clin Psychiatry. 2013 Feb; 74(2):167-9. 2313467
    View PubMed
11. Swann AC, Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, Scott J, Ha K, Suppes T. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry. 2013 Jan 1; 170(1):31-42. 2300511
    View PubMed
12. Port JD, Rampton KE, Shu Y, Manduca A, Frye MA. Short TE 7Li-MRS confirms Bi-exponential lithium T2 relaxation in humans and clearly delineates two patient subtypes. J Magn Reson Imaging. 2013; 37(6):1451-9. 2329867
    
13. Abulseoud O, Karpyak V, Schneekloth T, Hall-Flavin D, Loukianova L, Geske J, Biernacka J, Mrazek D, Frye M. A Retrospective Study of Gender Differences in Depressive Symptoms, Risk of Relapse with Alcohol Dependence. Am J Addiction. 2013. 2321345
    
14. Knight EJ, Min HK, Hwang SC, Marsh MP, Paek S, Kim I, Felmlee JP, Abulseoud OA, Bennet KE, Frye MA, Lee KH. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study. PLoS One. 2013; 8(2):e56640. Epub 2013 Feb 18. 2306761
    View PubMed
15. Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Kupka RW, Grunze H, Rowe M. Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. J Affect Disord. 2013; 147(1-3):288-94. 2316270
    
16. Biernacka JM, Geske JR, Schneekloth TD, Frye MA, Cunningham JM, Choi DS, Tapp CL, Lewis BR, Drews MS, L Pietrzak T, Colby CL, Hall-Flavin DK, Loukianova LL, Heit JA, Mrazek DA, Karpyak VM. Replication of genome wide association studies of alcohol dependence: support for association with variation in ADH1C. PLoS One. 2013; 8(3):e58798. Epub 2013 Mar 13. 2311824
    View PubMed
17. Leboyer M, Soreca I, Scott J, Frye M, Henry C, Tamouza R, Kupfer DJ. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord. 2012 Dec 1; 141(1):1-10. Epub 2012 Apr 11. 2269913
    View PubMed
18. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, Klassen B, Stead M, Fields JA, Frye MA. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):102-10. 2238269
    View PubMed
19. Bauer M, Glenn T, Alda M, Andreassen OA, Ardau R, Bellivier F, Berk M, Bjella TD, Bossini L, Del Zompo M, Dodd S, Fagiolini A, Frye MA, Gonzalez-Pinto A, Henry C, Kapczinski F, Kliwicki S, Konig B, Kunz M, Lafer B, Lopez-Jaramillo C, Manchia M, Marsh W, Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disord. 2012 Sep; 14(6):654-63. Epub 2012 May 21. 2247748
    View PubMed
20. Anderson RJ, Frye MA, Abulseoud OA, Lee KH, McGillivray JA, Berk M, Tye SJ. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev. 2012 Sep; 36(8):1920-33. Epub 2012 Jun 18. 2261670
    View PubMed
21. Karpyak VM, Winham SJ, Biernacka JM, Cunningham JM, Lewis KA, Geske JR, Colby CL, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Frye MA, Heit JA, Mrazek DA. Association of GATA4 sequence variation with alcohol dependence. Addict Biol. 2012 Aug 02. [Epub ahead of print] 2262818
    View PubMed
22. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. J Clin Psychiatry. 2012 Jul; 73(7):924-30. Epub 2012 Mar 20. 2267625
    View PubMed
23. Hinton DJ, Lee MR, Jacobson TL, Mishra PK, Frye MA, Mrazek DA, Macura SI, Choi DS. Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1. Neuropharmacology. 2012 Jun; 62(8):2480-8. 2242381
    View PubMed
24. Gitlin M, Frye MA. Maintenance therapies in bipolar disorders. Bipolar Disord. 2012 May; 14 Suppl 2:51-65. 2240810
    View PubMed
25. Malhi GS, Bargh DM, Cashman E, Frye MA, Gitlin M. The clinical management of bipolar disorder complexity using a stratified model. Bipolar Disord. 2012 May; 14 Suppl 2:66-89. 2240760
    View PubMed
26. Malhi GS, Bargh DM, McIntyre R, Gitlin M, Frye MA, Bauer M, Berk M. Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder. Bipolar Disord. 2012 May; 14 Suppl 2:1-21. 2242619
    View PubMed
27. Chopra A, Kolla BP, Mansukhani MP, Netzel P, Frye MA. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry. 2012 May-Jun; 34(3):290-8. Epub 2012 Feb 02. 2223136
    View PubMed
28. Biernacka JM, McElroy SL, Crow S, Sharp A, Benitez J, Veldic M, Kung S, Cunningham JM, Post RM, Mrazek D, Frye MA. Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. J Affect Disord. 2012 Jan; 136(1-2):e21-9. Epub 2011 Jun 15. 2172278
    View PubMed
29. Li X, Frye MA, Shelton RC. Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology. 2012 Jan; 37(1):77-101. Epub 2011 Sep 07. 2221578
    View PubMed
30. Lapid MI, Drake MT, Geske JR, Mundis CB, Hegard TL, Kung S, Frye MA. Hypovitaminosis D in psychogeriatric inpatients J Nutr Health Aging. 2012. [Epub ahead of print] 2238698
    
31. Kolla BP, Schneekloth TD, Biernacka JM, Frye MA, Mansukhani MP, Hall-Flavin DK, Karpyak VM, Loukianova LL, Lesnick TG, Mrazek D. Trazodone and alcohol relapse: a retrospective study following residential treatment. Am J Addict. 2011 Nov-Dec; 20(6):525-9. Epub 2011 Sep 29. 2199739
    View PubMed
32. Frye MA, Ha K, Kanba S, Kato T, McElroy SL, Ozerdem A, Vazquez G, Vieta E. International consensus group on depression prevention in bipolar disorder. J Clin Psychiatry. 2011 Oct; 72(10):1295-310. 2264522
    View PubMed
33. Williams MD, Shah ND, Wagie AE, Wood DL, Frye MA. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis. Psychiatr Serv. 2011 Sep; 62(9):1073-8. 2269914
    View PubMed
34. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J, Rowe M. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. Int Clin Psychopharmacol. 2011 Mar; 26(2):96-106. 2151442
    View PubMed
35. McElroy SL, Frye MA, Hellemann G, Altshuler L, Leverich GS, Suppes T, Keck PE, Nolen WA, Kupka R, Post RM. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord. 2011 Feb; 128(3):191-8. Epub 2010 Jul 31. 2120953
    View PubMed
36. Frye MA. Clinical practice. Bipolar disorder--a focus on depression. N Engl J Med. 2011 Jan 6; 364(1):51-9. 2141679
    View PubMed
37. Hall-Flavin DK, Schneekloth TD, Loukianova LL, Karpyak VM, Lesnick TG, Biernacka JM, Mrazek DA, Frye MA. Utilization of residential alcoholism treatment in bipolar disorder. Am J Addict. 2011 Jan-Feb; 20(1):40-4. Epub 2010 Nov 12. 2136150
    View PubMed
38. Shippee ND, Shah ND, Williams MD, Moriarty JP, Frye MA, Ziegenfuss JY. Differences in demographic composition and in work, social, and functional limitations among the populations with unipolar depression and bipolar disorder: results from a nationally representative sample. Health Qual Life Outcomes. 2011; 9:90. Epub 2011 Oct 13. 2203572
    View PubMed
39. Calabrese JR, Ketter TA, Youakim JM, Tiller JM, Yang R, Frye MA. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. J Clin Psychiatry. 2010 Oct; 71(10):1363-70. Epub 2010 Jul 27. 2130062
    View PubMed
40. Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010 Sep; 71(9):1176-86; quiz 1252-3. 2120954
    View PubMed
41. Gitlin MJ, Abulseoud O, Frye MA. Improving the design of maintenance studies for bipolar disorder. Curr Med Res Opin. 2010 Aug; 26(8):1835-42. 2110425
    View PubMed
42. Boykoff N, Schneekloth TD, Hall-Flavin D, Loukianova L, Karpyak VM, Stevens SR, Biernacka JM, Mrazek DA, Frye MA. Gender differences in the relationship between depressive symptoms and cravings in alcoholism. Am J Addict. 2010 Jul-Aug; 19(4):352-6. 2109359
    View PubMed
43. Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010 Jul; 71(7):864-72. 2112510
    View PubMed
44. Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. Am J Psychiatry. 2010 Jun; 167(6):708-15. Epub 2010 Mar 15. 2143931
    View PubMed
45. Frye MA. Treatment guidelines for acute manic and mixed episodes of bipolar disorder. Cns Spectrums. 2009 Dec; 14(Suppl 15):8-11. 1986422
    View PubMed
46. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. J Clin Psychiatry. 2009 Oct; 79(10):1424-31. 1971981
    View PubMed
47. Goldberg JF, Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo. J Clin Psychiatry. 2009 Sep; 70(9):1273-80. Epub 2009 Aug 11. 1969971
    View PubMed
48. Frye MA, Yatham L, Ketter TA, Goldberg J, Suppes T, Calabrese JR, Bowden CL, Bourne E, Bahn RS, Adams B. Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies. Acta Psychiatr Scand. 2009 Jul; 120(1):10-3. Epub 2009 Jan 31. 1920485
    View PubMed
49. Tye SJ, Frye MA, Lee KH. Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation. Mayo Clin Proc. 2009 Jun; 84(6):522-32. 1946967
    View PubMed
50. Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE Jr, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry. 2009 Apr; 70(4):450-7. Epub 2009 Apr 07. 1962364
    View PubMed
51. Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009 Feb; 166(2):164-72. Epub 2008 Nov 17. 1928124
    View PubMed
52. Kupka R, Frye MA. Diagnosis and treatment of rapid cycling bipolar disorder. In: Yatham LN; Kusumakar V editor. Bipolar disorder: A clinician's guide to treatment management. 2nd Edition. New York: Routledge/Taylor & Francis Group; 2009. p. 45-77. 1969990
    View PubMed
53. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008 Aug; 79(8):854-62. Epub 2007 Nov 6 2233159
    View PubMed
54. Frye MA. Diagnostic dilemmas and clinical correlates of mixed states in bipolar disorder. J Clin Psychiatry. 2008 May; 69(5):e13. 1894801
    View PubMed
55. Shivakumar G, Bernstein IH, Suppes T, Stanley Foundation Bipolar Network, Keck PE, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS, Mintz J, Post RM. Are bipolar mood symptoms affected by the phase of the menstrual cycle? J Womens Health (Larchmt) 2008 Apr; 17(3):473-8. 1972911
    View PubMed
56. Post RM, Luckenbaugh DA, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry. 2008 Feb; 192(2):150-1. 1899030
    View PubMed
57. Cardenas J, Frye MA, Marusak SL, Levander EM, Chirichigno JW, Lewis S, Nakelsky S, Hwang S, Mintz J, Altshuler LL. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 2008 Feb; 106(1-2):91-7. Epub 2007 Jul 12. 1898816
    View PubMed
58. Goldberg JF, Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, Suppes T, Post RM. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry. 2008 Jan 1; 63(1):125-30. Epub 2007 Jun 01. 1888467
    View PubMed
59. Abulseoud OA, Hellmann G, Calabrese JR, Verduin ML, Chirichigno JW, McKowen J, Gitlin MJ, Altshuler LL, Frye MA. Sex and bipolar subtype association with self-reported hazardous alcohol consumption in bipolar depression. Journal of Dual Diagnosis. 2008; 4(3):291-302. 1982687
    View PubMed
60. Hirschfeld RM, Calabrese JR, Frye MA, Lavori PW, Sachs G, Thase ME, Wagner KD. Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacol Bull. 2008; 40:7-14. 1990655
    View PubMed
61. Frye MA, Watzl J, Banakar S, O'Neill J, Mintz J, Davanzo P, Fischer J, Chirichigno JW, Ventura J, Elman S, Tsuang J, Walot I, Thomas MA. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. 2007 Dec; 32(12):2490-9. Epub 2007 Apr 11. 1858474
    View PubMed
62. Keck PE Jr, Frye MA, Thase ME. Bipolar depression: best practices for the hospitalized patient. CNS Spectr. 2007 Nov; 12(11 Suppl 19):1-13. 1972041
    View PubMed
63. Suppes T, Kelly DI, Keck PE Jr, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network. Int Clin Psychopharmacol. 2007 Nov; 22(6):376-81. 1848851
    View PubMed
64. Frye MA, Grunze H, Suppes T, McElroy SL, Keck PE Jr, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007 Aug; 164(8):1242-9. 1841357
    View PubMed
65. Levander E, Frye MA, McElroy S, Suppes T, Grunze H, Nolen WA, Kupka R, Keck PE Jr, Leverich GS, Altshuler LL, Hwang S, Mintz J, Post RM. Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. J Affect Disord. 2007 Aug; 101(1-3):211-7. Epub 2007 Jan 23. 1837082
    View PubMed
66. McDermott BE, Quanbeck CD, Frye MA. Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest. Bipolar Disord. 2007 Aug; 9(5):536-40. 1833082
    View PubMed
67. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE Jr, McElroy SL, Grunze H, Post RM. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord. 2007 Aug; 9(5):531-5. 1833121
    View PubMed
68. McElroy SL, Suppes T, Frye MA, Altshuler LL, Stanford K, Martens B, Leverich GS, Post RM, Keck PE Jr. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. J Affect Disord. 2007 Aug; 101(1-3):275-81. Epub 2007 Jan 16. 1805675
    View PubMed
69. McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, Mintz J, Kupka R, Nolen W, Leverich GS, Denicoff KD, Post RM, Keck PE Jr. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord. 2007 Jun; 9(4):426-34. 1931477
    View PubMed
70. Abulseoud O, Sane N, Cozzolino A, Kiriakos L, Mehra V, Gitlin M, Masseling S, Whybrow P, Altshuler LL, Mintz J, Frye MA. Free T4 index and clinical outcome in patients with depression. J Affect Disord. 2007 Jun; 100(1-3):271-7. Epub 2006 Nov 22. 1972043
    View PubMed
71. Leverich GS, Post RM, Keck PE Jr, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D. The poor prognosis of childhood-onset bipolar disorder. J Pediatr. 2007 May; 150(5):485-90. 1972044
    View PubMed
72. Nolen WA, Kupka RW, Hellemann G, Frye MA, Altshuler LL, Leverich GS, Suppes T, Keck PE Jr, McElroy S, Grunze H, Mintz J, Post RM. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand. 2007 May; 115(5):360-5. 1931462
    View PubMed
73. Frye MA, Thomas MA, Yue K, Binesh N, Davanzo P, Ventura J, O'Neill J, Guze B, Curran JG, Mintz J. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Res. 2007 Apr 15; 154(3):259-65. Epub 2007 Mar 07. 1822520
    View PubMed
74. Frye MA, Tsai GE, Huggins T, Coyle JT, Post RM. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder. Biol Psychiatry. 2007 Jan 15; 61(2):162-6. Epub 2006 Jun 02. 1805589
    View PubMed
75. Frye MA, Thomas MA, Yue K, Binesh N, Davanzo P, Ventura J, O’Neil J, Barry Guze B, Curran JG, Mintz J. Reduced Basal Ganglia [NAA] and NAA/Cr in Mania: A 3T 1H MRS Study. J Psychiatric Research Neuroimaging. 2007; 154:259-65. 1817326
    
76. Fan AH, Frye MA, Masseling SJ, Hwang S, Cozzolino A, Kiriakos L, Mintz J, Sane N, Gitlin MJ, Altshuler L. Increased suicidality in mania complicated by alcoholism. Psychiatry. 2007; 4:34-9. 1990606
    View PubMed
77. McElroy SL, Frye MA, Goldberg JF, McIntyre RS. Diagnosis and treatment strategies for mixed episodes in bipolar disorder. J Clin Psychiatry. 2007; 68(12):1971-81. 1975653
    View PubMed
78. Post RM, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Grunze H. New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. Curr Psychiatry Rep. 2006 Dec; 8(6):489-97. 1972046
    View PubMed
79. Frye MA, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disord. 2006 Dec; 8(6):677-85. 1794510
    View PubMed
80. Abulseoud O, Sane N, Cozzolino A, Kiriakos L, Mehra V, Gitlin M, Masseling S, Whybrow P, Altshuler LL, Mintz J, Frye MA. Free T(4) index and clinical outcome in patients with depression. J Affect Disord. 2007. 1805599
    
81. Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006 Nov 1; 60(9):1020-2. Epub 2006 Jun 30. 1805597
    View PubMed
82. Frye MA, Yatham LN, Calabrese JR, Bowden CL, Ketter TA, Suppes T, Adams BE, Thompson TR. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry. 2006 Nov; 67(11):1721-8. 1794578
    View PubMed
83. Altshuler LL, Post RM, Black DO, Keck PE Jr, Nolen WA, Frye MA, Suppes T, Grunze H, Kupka RW, Leverich GS, McElroy SL, Walden J, Mintz J. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry. 2006 Oct; 67(10):1551-60. 1805598
    View PubMed
84. Frye MA, Calabrese JR, Reed ML, Hirschfeld RM. Healthcare resource utilization in bipolar depression compared with unipolar depression: results of a United States population-based study. CNS Spectr. 2006 Sep; 11(9):704-10; quiz 719. 1805559
    View PubMed
85. Brook M, Hilty DM, Liu W, Hu R, Frye MA. Discharge against medical advice from inpatient psychiatric treatment: a literature review. Psychiatr Serv. 2006 Aug; 57(8):1192-8. 1805562
    View PubMed
86. Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry. 2006 Aug; 189:124-31. 1805563
    View PubMed
87. Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R, DeVeaugh-Geiss A, Thompson TR. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry. 2006 Jun 1; 59(11):1061-4. 1805585
    View PubMed
88. Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE Jr, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry. 2006 Feb; 163(2):313-5. 1805560
    View PubMed
89. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006 Feb; 163(2):232-9. 1805561
    View PubMed
90. Calabrese JR, Muzina DJ, Kemp DE, Sachs GS, Frye MA, Thompson TR, Klingman D, Reed ML, Hirschfeld RM. Predictors of bipolar disorder risk among patients currently treated for major depression. MedGenMed. 2006; 8(3):38. Epub 2006 Aug 15. 1972045
    View PubMed
91. Quanbeck CD, McDermott BE, Frye MA. Clinical and legal characteristics of inmates with bipolar disorder. Curr Psychiatry Rep. 2005 Dec; 7(6):478-84. 1805558
    View PubMed
92. Frye MA, Calabrese JR, Reed ML, Wagner KD, Lewis L, McNulty J, Hirschfeld RM. Use of health care services among persons who screen positive for bipolar disorder. Psychiatr Serv. 2005 Dec; 56(12):1529-33. 1805552
    View PubMed
93. Rasgon NL, Reynolds MF, Elman S, Saad M, Frye MA, Bauer M, Altshuler LL. Longitudinal evaluation of reproductive function in women treated for bipolar disorder. J Affect Disord. 2005 Dec; 89(1-3):217-25. Epub 2005 Sep 19. 1805556
    View PubMed
94. Suppes T, Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, Keck PE Jr, Nolen WA, Leverich GS, Grunze H, Rush AJ, Post RM. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry. 2005 Oct; 62(10):1089-96. 1805557
    View PubMed
95. Quanbeck CD, Stone DC, McDermott BE, Boone K, Scott CL, Frye MA. Relationship between criminal arrest and community treatment history among patients with bipolar disorder. Psychiatr Serv. 2005 Jul; 56(7):847-52. 1805554
    View PubMed
96. Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE Jr, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry. 2005 Jul; 162(7):1273-80. 1805555
    View PubMed
97. Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich G, Grunze H, Walden J, Post R, Mintz J. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord. 2005 Jun; 7(3):246-59. 1805549
    View PubMed
98. McElroy SL, Suppes T, Keck PE Jr, Black D, Frye MA, Altshuler LL, Nolen WA, Kupka RW, Leverich GS, Walden J, Grunze H, Post RM. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry. 2005 May; 66(5):617-24. 1805550
    View PubMed
99. Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL, Mandelkern MA, Bramen J, Voytek B, Woods R, Mazziotta JC, Whybrow PC. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry. 2005 May; 10(5):456-69. 1805553
    View PubMed
100. Post RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. J Clin Psychiatry. 2005 Mar; 66(3):370-4. 1805551
     View PubMed
101. Calabrese JR, Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry. 2004 Nov; 65(11):1499-504. 1805542
     View PubMed
102. Gitlin M, Altshuler LL, Frye MA, Suri R, Huynh EL, Fairbanks L, Bauer M, Korenman S. Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. J Psychiatry Neurosci. 2004 Sep; 29(5):383-6. 1805544
     View PubMed
103. State RC, Frye MA, Altshuler LL, Strober M, DeAntonio M, Hwang S, Mintz J. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. J Clin Psychiatry. 2004 Aug; 65(8):1057-63. 1805546
     View PubMed
104. Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE Jr, Leverich GS, Post RM. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry. 2004 Aug; 161(8):1447-54. 1805548
     View PubMed
105. Quanbeck CD, Stone DC, Scott CL, McDermott BE, Altshuler LL, Frye MA. Clinical and legal correlates of inmates with bipolar disorder at time of criminal arrest. J Clin Psychiatry. 2004 Feb; 65(2):198-203. 1805547
     View PubMed
106. Frye MA, Gitlin MJ, Altshuler LL. Unmet needs in bipolar depression. Depress Anxiety. 2004; 19(4):199-208. 1805543
     View PubMed
107. Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J, Stanley Foundation Bipolar Network. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003 Dec; 5(6):396-406. 1805541
     View PubMed
108. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord. 2003 Oct; 5(5):310-9. 1805540
     View PubMed
109. Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003 Jul; 160(7):1252-62. 1805539
     View PubMed
110. Quanbeck C, Frye M, Altshuler L. Mania and the law in California: understanding the criminalization of the mentally ill. Am J Psychiatry. 2003 Jul; 160(7):1245-50. 1805582
     View PubMed
111. Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS, Rush AJ, Post RM. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Compr Psychiatry. 2003 Jul-Aug; 44(4):263-9. 1972047
     View PubMed
112. Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry. 2003 Jul; 160(7):1263-71. 1972048
     View PubMed
113. Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry. 2003 May 15; 53(10):906-13. 1805583
     View PubMed
114. Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Denicoff KD, Obrocea G, Nolen WA, Kupka R, Walden J, Grunze H, Perez S, Luckenbaugh DA, Post RM. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry. 2003 May; 64(5):506-15. 1805533
     View PubMed
115. Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003 May; 160(5):883-9. 1805537
     View PubMed
116. Altshuler LL, Frye MA, Gitlin MJ. Acceleration and augmentation strategies for treating bipolar depression. Biol Psychiatry. 2003 Apr 15; 53(8):691-700. 1805532
     View PubMed
117. Frye MA, Gitlin MJ, Altshuler LL. Treating acute mania. J Fam Pract. 2003 Mar; Suppl:S10-3. 1805531
     View PubMed
118. Frye MA, Pazzaglia PJ, George MS, Luckenbaugh DA, Vanderham E, Davis CL, Rubinow DR, Post RM. Low CSF somatostatin associated with response to nimodipine in patents with affective illness. Biol Psychiatry. 2003 Jan 15; 53(2):180-3. 1805535
     View PubMed
119. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003 Jan; 64(1):53-9. 1805536
     View PubMed
120. Hirschfeld RM, Holzer C, Calabrese JR, Weissman M, Reed M, Davies M, Frye MA, Keck P, McElroy S, Lewis L, Tierce J, Wagner KD, Hazard E. Validity of the mood disorder questionnaire: a general population study. Am J Psychiatry. 2003 Jan; 160(1):178-80. 1805538
     View PubMed
121. Calabrese JR, Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, Shelton MD, Goodwin FK, Frye MA, Kusumakar V. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry. 2002 Nov; 63(11):1012-9. 1972049
     View PubMed
122. Altshuler LL, Gitlin MJ, Mintz J, Leight KL, Frye MA. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry. 2002 Sep; 63(9):807-11. 1805528
     View PubMed
123. State RC, Altshuler LL, Frye MA. Mania and attention deficit hyperactivity disorder in a prepubertal child: diagnostic and treatment challenges. Am J Psychiatry. 2002 Jun; 159(6):918-25. 1805527
     View PubMed
124. Li X, Ketter TA, Frye MA. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? J Affect Disord. 2002 May; 69(1-3):1-14. 1805529
     View PubMed
125. McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, Altshuler L, Denicoff KD, Nolen WA, Kupka R, Grunze H, Walden J, Post RM. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002 Mar; 63(3):207-13. 1805530
     View PubMed
126. Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry. 2001 Oct; 158(10):1617-22. 1805526
     View PubMed
127. Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord. 2001 Oct; 3(5):259-65. 1805522
     View PubMed
128. Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J. The Stanley Foundation Bipolar Network. I. Rationale and methods. Br J Psychiatry Suppl. 2001 Jun; 41:s169-76. 1805521
     View PubMed
129. Kupka RW, Nolen WA, Altshuler LL, Denicoff KD, Frye MA, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, Suppes T, Post RM. The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry Suppl. 2001 Jun; 41:s177-83. 1805525
     View PubMed
130. McElroy SL, Altshuler LL, Suppes T, Keck PE Jr, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001 Mar; 158(3):420-6. 1805524
     View PubMed
131. Post RM, Frye MA, Denicoff KD, Leverich GS, Dunn RT, Osuch EA, Speer AM, Obrocea G, Jajodia K. Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review. Bipolar Disord. 2000 Dec; 2(4):305-15. 1805520
     View PubMed
132. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol. 2000 Dec; 20(6):607-14. 1805516
     View PubMed
133. McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen J, Leverich GS, Post RM. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry. 2000 Jun 15; 47(12):1025-33. 1805517
     View PubMed
134. Vawter MP, Frye MA, Hemperly JJ, VanderPutten DM, Usen N, Doherty P, Saffell JL, Issa F, Post RM, Wyatt RJ, Freed WJ. Elevated concentration of N-CAM VASE isoforms in schizophrenia. J Psychiatr Res. 2000 Jan-Feb; 34(1):25-34. 1972050
     View PubMed
135. Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry. 2000 Jan; 61(1):9-15. 1805519
     View PubMed
136. Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D, Leverich GS, Post RM. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. Am J Psychiatry. 1999 Dec; 156(12):1909-14. 1805505
     View PubMed
137. Altshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord. 1999 Sep; 1(1):61-5. 1805580
     View PubMed
138. Goldstein TR, Frye MA, Denicoff KD, Smith-Jackson E, Leverich GS, Bryan AL, Ali SO, Post RM. Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. J Clin Psychiatry. 1999 Aug; 60(8):563-7; quiz 568-9. 1805507
     View PubMed
139. Ketter TA, Frye MA, Cora-Locatelli G, Kimbrell TA, Post RM. Metabolism and excretion of mood stabilizers and new anticonvulsants. Cell Mol Neurobiol. 1999 Aug; 19(4):511-32. 1805511
     View PubMed
140. Frye MA, Dunn RT, Gary KA, Kimbrell TA, Callahan AM, Luckenbaugh DA, Cora-Locatelli G, Vanderham E, Winokur A, Post RM. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression. Biol Psychiatry. 1999 Apr 15; 45(8):1049-52. 1805509
     View PubMed
141. Little JT, Ketter TA, Mathe AA, Frye MA, Luckenbaugh D, Post RM. Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biol Psychiatry. 1999 Feb 1; 45(3):285-9. 1805513
     View PubMed
142. Frye MA, Kimbrell TA, Dunn RT, Piscitelli S, Grothe D, Vanderham E, Cora-Locatelli G, Post RM, Ketter TA. Gabapentin does not alter single-dose lithium pharmacokinetics. J Clin Psychopharmacol. 1998 Dec; 18(6):461-4. 1805501
     View PubMed
143. Pazzaglia PJ, Post RM, Ketter TA, Callahan AM, Marangell LB, Frye MA, George MS, Kimbrell TA, Leverich GS, Cora-Locatelli G, Luckenbaugh D. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol. 1998 Oct; 18(5):404-13. 1805502
     View PubMed
144. Post RM, Denicoff KD, Frye MA, Dunn RT, Leverich GS, Osuch E, Speer A. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology. 1998 Oct; 38(3):152-66. 1805500
     View PubMed
145. Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT. Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology. 1998 Sep; 19(3):206-19. 1805504
     View PubMed
146. Dunn RT, Frye MS, Kimbrell TA, Denicoff KD, Leverich GS, Post RM. The efficacy and use of anticonvulsants in mood disorders. Clin Neuropharmacol. 1998 Jul-Aug; 21(4):215-35. 1805578
     View PubMed
147. McElroy SL, Frye M, Denicoff K, Altshuler L, Nolen W, Kupka R, Suppes T, Keck PE Jr, Leverich GS, Kmetz GF, Post RM. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord. 1998 May; 49(2):119-22. 1805573
     View PubMed
148. Parekh PI, Ketter TA, Altshuler L, Frye MA, Callahan A, Marangell L, Post RM. Relationships between thyroid hormone and antidepressant responses to total sleep deprivation in mood disorder patients. Biol Psychiatry. 1998 Mar 1; 43(5):392-4. 1805498
     View PubMed
149. Bonds C, Frye MA, Coudreaut MF, Cunningham M, Spearing M, McGuire M, Guze B. Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT. 1998 Mar; 14(1):36-41. 1805499
     View PubMed
150. Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Cora-Locatelli G, Post RM. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord. 1998 Mar; 48(2-3):91-104. 1805497
     View PubMed
151. Goldberg JF, Altshuler LL, Frye MA, Keck PE. The pharmacoeconomics of treating bipolar illness with divalproex sodium. Dir Psychiatry. 1998; 18:113-28. 1805587
     
152. Post RM, Kramlinger KG, Joffe RT, Roy-Byrne PP, Rosoff A, Frye MA, Huggins T. Rapid cycling bipolar affective disorder: lack of relation to hypothyroidism. Psychiatry Res. 1997 Aug 29; 72(1):1-7. 1016846
     View PubMed
153. Callahan AM, Frye MA, Marangell LB, George MS, Ketter TA, L'Herrou T, Post RM. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol Psychiatry. 1997 Feb 1; 41(3):264-72. 1805493
     View PubMed
154. Frye MA, Altshuler LL. Selection of initial treatment for bipolar disorder, manic phase. Mod Probl Pharmacopsychiatry. 1997; 25:88-113. 1805494
     View PubMed
155. Post RM, Denicoff KD, Frye MA, Leverich GS. Algorithms for bipolar mania. Mod Probl Pharmacopsychiatry. 1997; 25:114-45. 1805495
     View PubMed
156. Post RM, Leverich GS, Denicoff KD, Frye MA, Kimbrell TA, Dunn R. Alternative approaches to refractory depression in bipolar illness. Depress Anxiety. 1997; 5(4):175-89. 1805496
     View PubMed
157. Post RM, Denicoff KD, Leverich GS, Frye MA. Drug-induced switching in bipolar disorder: prevention and management. CNS Drugs. 1997; 8:352-65. 1805570
     
158. Post RM, Weiss SRR, Ketter TA, Denicoff KD, George MS, Frye MA, Leverich GR. The kindling model: implications for the etiology and treatment of mood disorders. Current Review Mood & Anxiety Disorders. 1997; 1:113-26. 1805586
     
159. Post RM, Ketter TA, Denicoff K, Pazzaglia PJ, Leverich GS, Marangell LB, Callahan AM, George MS, Frye MA. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996 Nov; 128(2):115-29. 1805492
     View PubMed
160. Poltorak M, Frye MA, Wright R, Hemperly JJ, George MS, Pazzaglia PJ, Jerrels SA, Post RM, Freed WJ. Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem. 1996 Apr; 66(4):1532-8. 1805491
     View PubMed
161. Frye MA, Altshuler LL, Szuba MP, Finch NN, Mintz J. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. J Clin Psychiatry. 1996 Jan; 57(1):17-21. 1805488
     View PubMed
162. Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Suppl. 1996; 11:153-80. 1805566
     View PubMed
163. Post RM, Weiss SR, Smith M, Rosen J, Frye M. Stress, conditioning, and the temporal aspects of affective disorders. Ann N Y Acad Sci. 1995 Dec 29; 771:677-96. 1805564
     View PubMed
164. Frye MA, Coudreaut MF, Hakeman SM, Shah BG, Strouse TB, Skotzko CE. Continuous droperidol infusion for management of agitated delirium in an intensive care unit. Psychosomatics. 1995 May-Jun; 36(3):301-5. 1805487
     View PubMed
165. Coudreaut MF, Frye MA, Pynoos R. Civil unrest and exacerbation of psychiatric symptoms: a case series. J Nerv Ment Dis. 1995 Feb; 183(2):109-11. 1805486
     View PubMed
166. Frye MA, Melton LJ 3rd, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, Riggs BL. Osteoporosis and calcification of the aorta. Bone Miner. 1992 Nov; 19(2):185-94. 1313812
     View PubMed
167. Melton LJ 3rd, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989 May; 129(5):1000-11. 69042
     View PubMed